Tegaserod for the treatment of Irritable Bowel syndrome
01 Pubblicazione su rivista
Madia Valentina Noemi, Messore Antonella, Saccoliti Francesco, Tudino Valeria, De Leo Alessandro, De Vita Daniela, Bortolami Martina, Scipione Luigi, Pindinello Ivano, Costi Roberta, Di Santo Roberto
ISSN: 1871-5230
Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C).